UNITY is developing a new class of therapeutics to reduce, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to eliminate or modulate senescent cells selectively, thereby providing transformative benefit in age-related ophthalmologic and neurologic disorders.